Jacopo Sgrignani

2.2k total citations
61 papers, 1.2k citations indexed

About

Jacopo Sgrignani is a scholar working on Molecular Biology, Computational Theory and Mathematics and Materials Chemistry. According to data from OpenAlex, Jacopo Sgrignani has authored 61 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 13 papers in Computational Theory and Mathematics and 10 papers in Materials Chemistry. Recurrent topics in Jacopo Sgrignani's work include Computational Drug Discovery Methods (13 papers), DNA and Nucleic Acid Chemistry (7 papers) and Enzyme Structure and Function (7 papers). Jacopo Sgrignani is often cited by papers focused on Computational Drug Discovery Methods (13 papers), DNA and Nucleic Acid Chemistry (7 papers) and Enzyme Structure and Function (7 papers). Jacopo Sgrignani collaborates with scholars based in Italy, Switzerland and United States. Jacopo Sgrignani's co-authors include Alessandra Magistrato, Andrea Cavalli, Giovanni Grazioso, Giorgio Colombo, Carlo V. Catapano, Milos Matkovic, Jessica Merulla, Carmen Lammi, Anna Arnoldi and Rolf Krause and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and Advanced Functional Materials.

In The Last Decade

Jacopo Sgrignani

58 papers receiving 1.2k citations

Peers

Jacopo Sgrignani
Daniel S. Sem United States
Johannes C. Hermann United States
Patrizio Mattei Switzerland
Tatu Pantsar Finland
Cynthia D. Sommers United States
Jacopo Sgrignani
Citations per year, relative to Jacopo Sgrignani Jacopo Sgrignani (= 1×) peers Wen‐Xu Hong

Countries citing papers authored by Jacopo Sgrignani

Since Specialization
Citations

This map shows the geographic impact of Jacopo Sgrignani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacopo Sgrignani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacopo Sgrignani more than expected).

Fields of papers citing papers by Jacopo Sgrignani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacopo Sgrignani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacopo Sgrignani. The network helps show where Jacopo Sgrignani may publish in the future.

Co-authorship network of co-authors of Jacopo Sgrignani

This figure shows the co-authorship network connecting the top 25 collaborators of Jacopo Sgrignani. A scholar is included among the top collaborators of Jacopo Sgrignani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacopo Sgrignani. Jacopo Sgrignani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sanchez, Aurore, Raphaël Guérois, Jacopo Sgrignani, et al.. (2025). EXO1 promotes the meiotic MLH1-MLH3 endonuclease through conserved interactions with MLH1, MSH4 and DNA. Nature Communications. 16(1). 4141–4141. 2 indexed citations
2.
Sgrignani, Jacopo, Alberto Ongaro, Alessandro Dolmella, et al.. (2025). New Synthesis and Pharmacological Evaluation of Enantiomerically Pure (R)- and (S)-Methadone Metabolites as N-Methyl-d-aspartate Receptor Antagonists. Journal of Medicinal Chemistry. 68(5). 5455–5470. 1 indexed citations
3.
Sgrignani, Jacopo, et al.. (2025). AI-assisted design of ligands for lipocalin-2. Frontiers in Immunology. 16. 1631868–1631868.
4.
Ράμπιας, Θεόδωρος, Annelies Stevaert, Jacopo Sgrignani, et al.. (2024). Exploration of isatin-based inhibitors of SARS-CoV-2 Nsp15 endoribonuclease. European Journal of Medicinal Chemistry. 279. 116886–116886. 1 indexed citations
5.
Ratti, A., Fabio Forlani, Matteo Mori, et al.. (2023). Mechanistic Insights into the Antibiofilm Mode of Action of Ellagic Acid. Pharmaceutics. 15(6). 1757–1757. 12 indexed citations
6.
Chung, Elaine Y., Giulio Sartori, Maurilio Ponzoni, et al.. (2023). ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells. British Journal of Haematology. 203(2). 244–254. 2 indexed citations
7.
Sgrignani, Jacopo, et al.. (2023). Tau protein binds to the P53 E3 ubiquitin ligase MDM2. Scientific Reports. 13(1). 10208–10208. 8 indexed citations
8.
Fava, Maurizio, Stephen M. Stahl, Sara De Martin, et al.. (2023). Esmethadone-HCl (REL-1017): a promising rapid antidepressant. European Archives of Psychiatry and Clinical Neuroscience. 273(7). 1463–1476. 21 indexed citations
9.
Cavalli, Andrea, Jacopo Sgrignani, Jonathan P. Sleeman, et al.. (2022). CEMIP (HYBID, KIAA1199): structure, function and expression in health and disease. FEBS Journal. 290(16). 3946–3962. 20 indexed citations
10.
Curti, Laura, Dheeraj Shinde, Domenico Albino, et al.. (2021). EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancer. Nature Communications. 12(1). 4147–4147. 28 indexed citations
11.
Sgrignani, Jacopo & Andrea Cavalli. (2021). Computational Identification of a Putative Allosteric Binding Pocket in TMPRSS2. Frontiers in Molecular Biosciences. 8. 666626–666626. 7 indexed citations
12.
Gazzotti, Stefano, Filomena Sannio, Leonardo Lo Presti, et al.. (2020). Isonitrile-Based Multicomponent Synthesis of β-Amino Boronic Acids as β-Lactamase Inhibitors. Antibiotics. 9(5). 249–249. 12 indexed citations
13.
Spinello, Angelo, Federico Berti, Marzia Pennati, et al.. (2019). Rational design of allosteric modulators of the aromatase enzyme: An unprecedented therapeutic strategy to fight breast cancer. European Journal of Medicinal Chemistry. 168. 253–262. 34 indexed citations
14.
Sgrignani, Jacopo, et al.. (2018). Structural Biology of STAT3 and Its Implications for Anticancer Therapies Development. International Journal of Molecular Sciences. 19(6). 1591–1591. 123 indexed citations
15.
Sgrignani, Jacopo, Jingjing Chen, Andrea Alimonti, & Andrea Cavalli. (2018). How phosphorylation influences E1 subunit pyruvate dehydrogenase: A computational study. Scientific Reports. 8(1). 14683–14683. 16 indexed citations
16.
Sgrignani, Jacopo, Filomena De Luca, Hayarpi Torosyan, et al.. (2016). Structure-based approach for identification of novel phenylboronic acids as serine-β-lactamase inhibitors. Journal of Computer-Aided Molecular Design. 30(10). 851–861. 9 indexed citations
17.
Sgrignani, Jacopo, Andrea Cavalli, Giorgio Colombo, & Alessandra Magistrato. (2016). Enzymatic and Inhibition Mechanism of Human Aromatase (CYP19A1) Enzyme. A Computational Perspective from QM/MM and Classical Molecular Dynamics Simulations. Mini-Reviews in Medicinal Chemistry. 16(14). 1112–1124. 14 indexed citations
18.
Sgrignani, Jacopo, et al.. (2015). Covalent docking of selected boron-based serine beta-lactamase inhibitors. Journal of Computer-Aided Molecular Design. 29(5). 441–450. 18 indexed citations
19.
Sgrignani, Jacopo, Alessandra Magistrato, Matteo Dal Peraro, et al.. (2012). On the active site of mononuclear B1 metallo β-lactamases: a computational study. Journal of Computer-Aided Molecular Design. 26(4). 425–435. 8 indexed citations
20.
Sgrignani, Jacopo & Roberta Pierattelli. (2011). Nuclear magnetic resonance signal chemical shifts and molecular simulations: a multidisciplinary approach to modeling copper protein structures. JBIC Journal of Biological Inorganic Chemistry. 17(1). 71–79. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026